# Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase

> **NCT00520260** · PHASE4 · COMPLETED · sponsor: **Florida Eye Microsurgical Institute** · enrollment: 42 (actual)

## Conditions studied

- Dry Eye Disease
- Ocular Comfort

## Interventions

- **DRUG:** bromfenac
- **DRUG:** ketorolac

## Key facts

- **NCT ID:** NCT00520260
- **Lead sponsor:** Florida Eye Microsurgical Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2009-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00520260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00520260, "Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00520260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*